Dozens of researchers, including myself, worked for years to uncover that swine flu had leapt to humans from a pig in Mexico in 2009. We learned a lot about influenza evolution, pig farming, and outbreak risk along the way.
Sergii Mirnyi, one of the people who helped clean up after the 1986 disaster, says he founded Chornobyl University to promote much-needed interdisciplinary research on the Chernobyl Exclusion Zone.
Humanity was hoping to emerge from the COVID-19 pandemic this year. But viruses have plenty of tools at their disposal, and we should plan for a long-term future in which SARS-CoV-2 is a persistent threat.
Kristin Butcher and Mara Cuoto-Rodriguez discuss the development of a nucleic acid hybridization capture-based assay to detect and identify novel SARS-CoV-2 variants.
RNA sequencing technology lags far behind researchers’ ability to decode and understand DNA. The COVID-19 pandemic has highlighted this dangerous shortcoming.
The Scientist Creative Services Team | Jan 28, 2021
Join The Scientist on March 19 to discuss Lulu Miller’s book about a determined taxonomist whose life and work constitute a fable illustrating the hazards of categorization.
CDC investigators continue to search for the source of the bacteria that caused four infections—two of them lethal—in four different states. The Scientist spoke with melioidosis expert Bart Currie about the disease.
The makers of the CRISPR-based testing platform, called miSHERLOCK, say it could enable people at home or physicians in resource-limited environments to detect SARS-CoV-2—and eventually, other pathogens.
The Scientist Creative Services Team | Oct 22, 2020
TRACKMAN® Connected is a tablet with accessories and apps that makes pipetting faster and more verifiable, which improves reliability, traceability, and reproducibility at the bench.
An ability to build up higher concentrations of viral particles in people’s airways and mutations that might boost its ability to infect human cells could be what gives the Delta variant its evolutionary edge.
A long noncoding RNA from humans appeared to help the enzyme phenylalanine hydroxylase work better in a mouse model of phenylketonuria, the disorder characterized by reduced activity of that enzyme.
